Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and has become a public health concern worldwide. The hallmark of NAFLD is hepatic steatosis. Therefore, there is an urgent need to develop new therapeutic strategies that are efficacious and have...

Full description

Bibliographic Details
Main Authors: Dan Feng, Jun Zou, Dongfang Su, Haiyan Mai, Shanshan Zhang, Peiyang Li, Xiumei Zheng
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Nutrition & Metabolism
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12986-019-0410-3
_version_ 1818192239293104128
author Dan Feng
Jun Zou
Dongfang Su
Haiyan Mai
Shanshan Zhang
Peiyang Li
Xiumei Zheng
author_facet Dan Feng
Jun Zou
Dongfang Su
Haiyan Mai
Shanshan Zhang
Peiyang Li
Xiumei Zheng
author_sort Dan Feng
collection DOAJ
description Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and has become a public health concern worldwide. The hallmark of NAFLD is hepatic steatosis. Therefore, there is an urgent need to develop new therapeutic strategies that are efficacious and have minimal side effects in hepatic steatosis and NAFLD treatment. The present study aimed to investigate the effect of dietary supplement of curcumin on high-fat diet (HFD)-induced hepatic steatosis and the underlying mechanism. Methods ApoE−/− mice were fed a normal diet, high-fat diet (HFD) or HFD supplemented with curcumin (0.1% w/w) for 16 weeks. Body and liver weight, blood biochemical. parameters, and liver lipids were measured. Intestinal permeability, hepatic steatosis and mRNA and protein expressions of TLR4-related inflammatory signaling molecule were analyzed. Results The administration of curcumin significantly prevented HFD-induced body weight gain and reduced liver weight. Curcumin attenuated hepatic steatosis along with improved serum lipid profile. Moreover, curcumin up-regulated the expression of intestinal tight junction protein zonula occluden-1 and occludin, which further improved gut barrier dysfunction and reduced circulating lipopolysaccharide levels. Curcumin also markedly down-regulated the protein expression of hepatic TLR4 and myeloid differentiation factor 88 (MyD88), inhibited p65 nuclear translocation and DNA binding activity of nuclear factor-κB (NF-κB) in the liver. In addition, the mRNA expression of hepatic tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) as well as the plasma levels of TNF-α and IL-1β were also lowered by curcumin treatment. Conclusion These results indicated that curcumin protects against HFD-induced hepatic steatosis by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. The ability of curcumin to inhibit hepatic steatosis portrayed its potential as effective dietry intervention for NAFLD prevention.
first_indexed 2024-12-12T00:27:20Z
format Article
id doaj.art-6724715011af4a38972d3ae8ae56dae5
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-12-12T00:27:20Z
publishDate 2019-11-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-6724715011af4a38972d3ae8ae56dae52022-12-22T00:44:35ZengBMCNutrition & Metabolism1743-70752019-11-0116111110.1186/s12986-019-0410-3Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammationDan Feng0Jun Zou1Dongfang Su2Haiyan Mai3Shanshan Zhang4Peiyang Li5Xiumei Zheng6Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Preventive Medicine, School of Public Health, Sun Yat-sen University(Northern Campus)Department of Cardiology, Affiliated Nanhai Hospital of Southern Medical UniversityDepartment of Clinic Nutrition, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer CenterDepartment of Clinic Nutrition, The First Affiliated Hospital, Sun Yat-sen UniversityGuangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Preventive Medicine, School of Public Health, Sun Yat-sen University(Northern Campus)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Preventive Medicine, School of Public Health, Sun Yat-sen University(Northern Campus)Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Preventive Medicine, School of Public Health, Sun Yat-sen University(Northern Campus)Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and has become a public health concern worldwide. The hallmark of NAFLD is hepatic steatosis. Therefore, there is an urgent need to develop new therapeutic strategies that are efficacious and have minimal side effects in hepatic steatosis and NAFLD treatment. The present study aimed to investigate the effect of dietary supplement of curcumin on high-fat diet (HFD)-induced hepatic steatosis and the underlying mechanism. Methods ApoE−/− mice were fed a normal diet, high-fat diet (HFD) or HFD supplemented with curcumin (0.1% w/w) for 16 weeks. Body and liver weight, blood biochemical. parameters, and liver lipids were measured. Intestinal permeability, hepatic steatosis and mRNA and protein expressions of TLR4-related inflammatory signaling molecule were analyzed. Results The administration of curcumin significantly prevented HFD-induced body weight gain and reduced liver weight. Curcumin attenuated hepatic steatosis along with improved serum lipid profile. Moreover, curcumin up-regulated the expression of intestinal tight junction protein zonula occluden-1 and occludin, which further improved gut barrier dysfunction and reduced circulating lipopolysaccharide levels. Curcumin also markedly down-regulated the protein expression of hepatic TLR4 and myeloid differentiation factor 88 (MyD88), inhibited p65 nuclear translocation and DNA binding activity of nuclear factor-κB (NF-κB) in the liver. In addition, the mRNA expression of hepatic tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) as well as the plasma levels of TNF-α and IL-1β were also lowered by curcumin treatment. Conclusion These results indicated that curcumin protects against HFD-induced hepatic steatosis by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. The ability of curcumin to inhibit hepatic steatosis portrayed its potential as effective dietry intervention for NAFLD prevention.http://link.springer.com/article/10.1186/s12986-019-0410-3Hepatic steatosisCurcuminTight junction proteinLipopolysaccharideToll like receptor 4Nuclear factor-κB
spellingShingle Dan Feng
Jun Zou
Dongfang Su
Haiyan Mai
Shanshan Zhang
Peiyang Li
Xiumei Zheng
Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
Nutrition & Metabolism
Hepatic steatosis
Curcumin
Tight junction protein
Lipopolysaccharide
Toll like receptor 4
Nuclear factor-κB
title Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
title_full Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
title_fullStr Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
title_full_unstemmed Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
title_short Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
title_sort curcumin prevents high fat diet induced hepatic steatosis in apoe mice by improving intestinal barrier function and reducing endotoxin and liver tlr4 nf κb inflammation
topic Hepatic steatosis
Curcumin
Tight junction protein
Lipopolysaccharide
Toll like receptor 4
Nuclear factor-κB
url http://link.springer.com/article/10.1186/s12986-019-0410-3
work_keys_str_mv AT danfeng curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT junzou curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT dongfangsu curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT haiyanmai curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT shanshanzhang curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT peiyangli curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation
AT xiumeizheng curcuminpreventshighfatdietinducedhepaticsteatosisinapoemicebyimprovingintestinalbarrierfunctionandreducingendotoxinandlivertlr4nfkbinflammation